Last reviewed · How we verify
NCT06724146
Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance
NA trial testing Sofwave and Pure Impact in Skin Lax and Muscle Strength in 70 participants. Participants enrolled and being followed up; not accepting new ones.
1 October 2026
Quick facts
| Lead sponsor | Sofwave Medical LTD |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 5 August 2024 |
| Primary completion | 1 October 2026 |
| Estimated completion | 1 November 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sofwave and Pure Impact
Conditions studied
- Skin Lax and Muscle Strength — all drugs for Skin Lax and Muscle Strength →
Sponsor
Sofwave Medical LTD
Who can join
Adults 25 to 70, any sex, with Skin Lax and Muscle Strength. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06724146
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Sofwave Medical LTD trials
Trials by the same sponsor.
- NCT07094971 — Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles · NA · recruiting
- NCT06333067 — Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators · NA · recruiting
- NCT06104514 — Safety and Efficacy of SofWave Treatment to Lift the Upper Lip and Improve the Peri-Oral Rhytids · NA · completed
- NCT05882721 — Treatment for Improvement of Cellulite Appearance Using Form Applicator · NA · completed
- NCT05358327 — Treatment for Lifting Upper Arm Lax Skin · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06724146 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sofwave Medical LTD
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06724146.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing